Therapeutic application of monoclonal antibodies in cancer: advances and challenges
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic application of monoclonal antibodies in cancer: advances and challenges
Authors
Keywords
-
Journal
BRITISH MEDICAL BULLETIN
Volume 104, Issue 1, Pages 41-59
Publisher
Oxford University Press (OUP)
Online
2012-12-11
DOI
10.1093/bmb/lds032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10
- (2012) H Modjtahedi et al. BRITISH JOURNAL OF CANCER
- Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion Diagnostics
- (2012) D. R. Parkinson et al. CLINICAL CANCER RESEARCH
- The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer
- (2012) Judith R. Kroep et al. CURRENT PHARMACEUTICAL DESIGN
- Ipilimumab Targeting CD28-CTLA-4 Axis: New Hope in the Treatment of Melanoma
- (2012) Marko Lens et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Catumaxomab
- (2012) James E. Frampton DRUGS
- Cancer risk and prevention in a globalised world: Solving the public policy mismatch
- (2012) R. Sullivan et al. EUROPEAN JOURNAL OF CANCER
- Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions
- (2012) Mital Patel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bevacizumab: overview of the literature
- (2012) Maria Ignez Braghiroli et al. Expert Review of Anticancer Therapy
- Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancer
- (2012) N Ioannou Frontiers in Bioscience-Landmark
- Therapeutic Antibodies Against Cancer
- (2012) Mark J. Adler et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Monoclonal antibodies in hematological malignancies: Past, present and future
- (2012) I Tazi et al. Journal of Cancer Research and Therapeutics
- Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
- (2012) Yung-Jue Bang JOURNAL OF CLINICAL GASTROENTEROLOGY
- Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches
- (2012) Klervi Even-Desrumeaux et al. Molecular BioSystems
- Cancer biomarkers
- (2012) N. Lynn Henry et al. Molecular Oncology
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- Can next-generation antibodies offset biosimilar competition?
- (2012) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Cancer biomarkers: selecting the right drug for the right patient
- (2012) Gary J. Kelloff et al. NATURE REVIEWS DRUG DISCOVERY
- Brentuximab vedotin
- (2012) Anas Younes et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor Heterogeneity and Personalized Medicine
- (2012) Dan L. Longo NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
- (2012) Thuy Vu et al. Frontiers in Oncology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Interaction of tumor cells with the microenvironment
- (2011) Hendrik Ungefroren et al. Cell Communication and Signaling
- Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2-Positive Cancer
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
- (2011) Marion G. Ott et al. INTERNATIONAL JOURNAL OF CANCER
- Delivering affordable cancer care in high-income countries
- (2011) Richard Sullivan et al. LANCET ONCOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Antibody-based therapeutics to watch in 2011
- (2011) Janice M. Reichert mAbs
- Changing End Points in Breast-Cancer Drug Approval — The Avastin Story
- (2011) Ralph B. D'Agostino NEW ENGLAND JOURNAL OF MEDICINE
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy
- (2010) Diane Seimetz et al. CANCER TREATMENT REVIEWS
- Cancer stem cells as the relevant biomass for drug discovery
- (2010) Raymond J Winquist et al. CURRENT OPINION IN PHARMACOLOGY
- Tumor–stromal cell interactions and opportunities for therapeutic intervention
- (2010) Taturo Udagawa et al. CURRENT OPINION IN PHARMACOLOGY
- HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20low expressing tumor cells that resist rituximab-mediated lysis
- (2010) T. van Meerten et al. HAEMATOLOGICA
- Have we overestimated the benefit of human(ized) antibodies?
- (2010) Daniel R. Getts et al. mAbs
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- Production of antibodies in plants: status after twenty years
- (2010) Benoit De Muynck et al. PLANT BIOTECHNOLOGY JOURNAL
- Refocusing the War on Cancer: The Critical Role of Personalized Treatment
- (2010) A. Potti et al. Science Translational Medicine
- Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities
- (2009) Helmout Modjtahedi et al. ANTI-CANCER DRUGS
- Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
- (2009) Roland E. Kontermann BIODRUGS
- Antibodies for Therapeutic Uses and the Evolution of Biotechniques
- (2009) P. Nieri et al. CURRENT MEDICINAL CHEMISTRY
- American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
- (2009) Neal J. Meropol et al. JOURNAL OF CLINICAL ONCOLOGY
- Animal-Derived Pharmaceutical Proteins
- (2009) EL-Rashdy M. Redwan JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
- Cancer stem cells—clinical relevance
- (2009) Richard J. Jones JOURNAL OF MOLECULAR MEDICINE-JMM
- Production of pharmaceutical proteins by transgenic animals
- (2008) Louis-Marie Houdebine COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
- Fully human antibodies from transgenic mouse and phage display platforms
- (2008) Nils Lonberg CURRENT OPINION IN IMMUNOLOGY
- Current perspective – Trastuzumab
- (2008) Peter S. Hall et al. EUROPEAN JOURNAL OF CANCER
- Production systems for recombinant antibodies
- (2008) Thomas Schirrmann Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More